| Literature DB >> 26517543 |
Roland Faigle1, Elisabeth B Marsh1, Rafael H Llinas1, Victor C Urrutia1.
Abstract
BACKGROUND ANDEntities:
Mesh:
Substances:
Year: 2015 PMID: 26517543 PMCID: PMC4627762 DOI: 10.1371/journal.pone.0141204
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical characteristics, ICU needs, and outcomes of post-tPA patients with positive and negative neuroimaging.
BP: blood pressure; SBP: systolic BP; DBP: diastolic BP; eGFR: estimated glomerular filtration rate; EF: ejection fraction; ICU: intensive care unit; LOS: length of stay; TIA: transient ischemic attack. P-values compare imaging positive and imaging negative patients by t-test/Wilcoxon rank-sum test for continuous variables, and Chi2/Fisher's exact test for categorical variables.
| Characteristics | All patients | Imaging positive | Imaging negative | p-value |
|---|---|---|---|---|
|
| 65.3 (15.5) | 67.5 (15.2) | 59.2 (15.1) |
|
| range | 28–94 | 28–94 | 29–89 | |
|
| 0.933 | |||
| African American | 98 (48.5) | 71 (48.0) | 27 (50.0) | |
| White | 102 (50.5) | 75 (50.6) | 27 (50.0) | |
| Other | 2 (1.0) | 2 (1.4) | 0 (0) | |
|
| 104 (51.5) | 67 (45.3) | 37 (68.5) |
|
|
| 9.4 (5.8) | 10.3 (6.1) | 7.0 (4.2) |
|
|
| ||||
| SBP | 163 (32.9) | 164 (31.1) | 162 (37.7) | 0.778 |
| DBP | 91 (19.5) | 91 (19.7) | 91 (19.1) | 0.886 |
|
| ||||
| < 3 hours | 150 (74.3) | 114 (77.0) | 36 (66.7) | 0.136 |
|
| 138 (59.7) | 141 (62.6) | 130 (50.3) | 0.249 |
|
| 67 (33.2) | 54 (36.5) | 13 (24.1) | 0.097 |
|
| ||||
| Hypertension | 159 (78.7) | 117 (79.5) | 42 (77.8) | 0.845 |
| Hyperlipidemia | 101 (50.0) | 77 (52.0) | 24 (44.4) | 0.340 |
| Diabetes mellitus | 55 (27.2) | 40 (27.0) | 15 (27.8) | 0.916 |
| Atrial fibrillation | 41 (20.3) | 37 (25.0) | 4 (7.4) |
|
| Prior ischemic stroke/TIA | 53 (26.2) | 34 (23.0) | 19 (35.2) | 0.081 |
| Current smoking | 66 (32.7) | 54 (36.5) | 12 (22.2) | 0.056 |
| Reduced EF (≤35%) | 29 (14.4) | 25 (16.9) | 4 (7.4) | 0.089 |
|
| ||||
| Antiplatelet agent | 89 (44.1) | 66 (44.6) | 23 (42.6) | 0.800 |
| Anticoagulation | 15 (7.3) | 14 (9.5) | 1 (1.9) | 0.075 |
| Statin | 80 (39.6) | 57 (38.5) | 23 (42.6) | 0.600 |
|
| 59 (29.2) | 54 (36.5) | 5 (9.3) |
|
|
| ||||
| By end of tPA infusion | 46 (22.8) | 41 (27.7) | 5 (9.3) |
|
| In first 24 hrs after tPA | 10 (5.0) | 10 (6.8) | 0 (0) |
|
| Beyond 24 hrs post tPA | 3 (1.5) | 3 (2.0) | 0 (0) | 0.551 |
|
| ||||
| IV antihypertensives | 23 (11.4) | 19 (12.8) | 4 (7.4) | 0.282 |
| Respiratory compromise | 27 (13.4) | 25 (16.9) | 2 (3.7) |
|
| BP augmentation | 5 (2.5) | 5 (3.4) | 0 (0) | 0.327 |
| Intraarterial therapy | 10 (5.0) | 10 (6.8) | 0 (0) | 0.065 |
| Cerebral edema therapy | 11 (5.5) | 11 (7.4) | 0 (0) |
|
| IV heart rate control | 4 (2.0) | 4 (2.7) | 0 (0) | 0.575 |
| Angioedema | 3 (1.5) | 3 (2.0) | 0 (0) | 0.566 |
| Intracerebral hemorrhage | ||||
| Symptomatic | 4 (2.0) | 4 (2.7) | 0 (0) | 0.575 |
| Any | 22 (10.9) | 22 (14.9) | 0 (0) |
|
| Other | 3 (1.5) | 3 (2.0 | 0 (0) | 0.566 |
|
| 5 (3–7) | 5 (3.5–11) | 3 (2–5) |
|
|
| ||||
| > 2 days | 37 (18.3) | 35 (23.7) | 2 (3.7) |
|
|
|
| |||
| Home | 105 (55.9) | 62 (46.3) | 43 (79.6) | |
| Acute Rehab | 51 (27.1) | 45 (33.6) | 6 (11.1) | |
| Subacute Rehab | 32 (17.0) | 27 (20.1) | 5 (9.3) | |
|
| 14 (6.9) | 14 (9.5) | 0 (0) |
|
Demographic and clinical variables of patients with DWI negative MRI after tPA requiring critical care resources.
ICU: intensive care unit; BP: blood pressure; SBP: systolic BP; DBP: diastolic BP; eGFR: estimated glomerular filtration rate; EF: ejection fraction. P-values compare patients with and without ICU needs by t-test for continuous variables, and Fisher's exact test for categorical variables.
| Characteristics | No ICU need | ICU need | p-value |
|---|---|---|---|
|
| 58.8 (15.0) | 63.4 (17.5) | 0.522 |
|
| 26 (53.1) | 1 (20.0) | 0.351 |
|
| 34 (69.4) | 3 (60.0) | 0.645 |
|
| 6.3 (5.4) | 14.2 (7.9) |
|
|
| |||
| < 3 hours | 32 (65.3) | 4 (80.0) | 0.655 |
|
| 1 (2.0) | 3 (60.0) |
|
|
| |||
| SBP | 155 (29.7) | 232 (39.6) |
|
| DBP | 88 (15.3) | 124 (23.1) |
|
|
| 129 (52.2) | 137 (26.7) | 0.749 |
|
| 9 (18.4) | 4 (80.0) |
|
|
| |||
| Hypertension | 37 (75.5) | 5 (100) | 0.575 |
| Hyperlipidemia | 21 (42.9) | 3 (60.0) | 0.646 |
| Diabetes mellitus | 13 (26.5) | 2 (40.0) | 0.610 |
| Atrial fibrillation | 4 (8.2) | 0 (0) | 1.000 |
| Prior ischemic stroke/TIA | 16 (32.7) | 1 (20.0) | 0.332 |
| Current smoking | 11 (22.5) | 1 (20.0) | 1.000 |
| Reduced EF (≤35%) | 4 (8.2) | 0 (0) | 1.000 |
|
| |||
| Antiplatelet agent | 22 (44.9) | 1 (20.0) | 0.380 |
| Anticoagulation | 1 (2.0) | 0 (0) | 1.000 |
| Statin | 20 (40.8) | 3 (60.0) | 0.640 |